Literature DB >> 18954692

Nonsurgical management of osteoarthritis in dogs.

Spencer A Johnston1, Ronald M McLaughlin, Steven C Budsberg.   

Abstract

Osteoarthritis (OA), although superficially considered to be deterioration of the joint associated with pain and dysfunction, is actually quite a complex condition. When considering treatment of OA, a multitude of biochemical, physical, and pathologic alterations must be recognized. This article presents a review of the published material regarding various nonsurgical treatments for OA. When there are no data regarding a specific treatment or when a statement is the opinion of the authors, such a deficiency is identified.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18954692     DOI： 10.1016/j.cvsm.2008.08.001

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN： 0195-5616            Impact factor:   2.093


  10 in total

1.  Effect of a diet enriched with green-lipped mussel on pain behavior and functioning in dogs with clinical osteoarthritis.

Authors:  Pascale Rialland; Sylvain Bichot; Bertrand Lussier; Maxim Moreau; Francis Beaudry; Jérôme R E del Castillo; Dominique Gauvin; Eric Troncy
Journal:  Can J Vet Res       Date:  2013-01       Impact factor: 1.310

2.  Feasibility and repeatability of thermal quantitative sensory testing in normal dogs and dogs with hind limb osteoarthritis-associated pain.

Authors:  Morika D Williams; Amy E Kirkpatrick; Emily Griffith; Javier Benito; Jon Hash; B D X Lascelles
Journal:  Vet J       Date:  2013-11-11       Impact factor: 2.688

3.  Biceps femoris muscle transposition for treatment of cranial cruciate ligament rupture in small breed dogs.

Authors:  Roberto Tamburro; Stefania Pinna; Anna Maria Tribuiani; Alessandra Panacea; Fabio Carli; Antonio Venturini
Journal:  J Vet Sci       Date:  2012-03       Impact factor: 1.672

4.  Intra-Articular Hyaluronic Acid Compared to Traditional Conservative Treatment in Dogs with Osteoarthritis Associated with Hip Dysplasia.

Authors:  Gabriel O L Carapeba; Poliana Cavaleti; Gabriel M Nicácio; Rejane B Brinholi; Rogério Giuffrida; Renata N Cassu
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-26       Impact factor: 2.629

Review 5.  Glucosamine and chondroitin use in canines for osteoarthritis: A review.

Authors:  Angel Bhathal; Meredith Spryszak; Christopher Louizos; Grace Frankel
Journal:  Open Vet J       Date:  2017-02-24

6.  Comparison of canine stifle kinematic analysis after two types of total knee arthroplasty: A cadaveric study.

Authors:  Chaiyakorn Thitiyanaporn; Nattapon Chantarapanich; Somchai Sompaisarnsilp; Naris Thengchaisri
Journal:  Vet World       Date:  2020-05-20

7.  Evaluation of the Effects of Undenatured Type II Collagen (UC-II) as Compared to Robenacoxib on the Mobility Impairment Induced by Osteoarthritis in Dogs.

Authors:  Marzia Stabile; Rossella Samarelli; Paolo Trerotoli; Laura Fracassi; Luca Lacitignola; Antonio Crovace; Francesco Staffieri
Journal:  Vet Sci       Date:  2019-09-04

8.  Identification of canine osteoarthritis using an owner-reported questionnaire and treatment monitoring using functional mobility tests.

Authors:  A Wright; D M Amodie; N Cernicchiaro; B D X Lascelles; A M Pavlock; C Roberts; D J Bartram
Journal:  J Small Anim Pract       Date:  2022-04-06       Impact factor: 1.669

9.  Intra-Articular Administration of Autologous Micro-Fragmented Adipose Tissue in Dogs with Spontaneous Osteoarthritis: Safety, Feasibility, and Clinical Outcomes.

Authors:  Offer Zeira; Simone Scaccia; Letizia Pettinari; Erica Ghezzi; Nimrod Asiag; Laura Martinelli; Daniele Zahirpour; Maria P Dumas; Martin Konar; Davide M Lupi; Laurence Fiette; Luisa Pascucci; Leonardo Leonardi; Alistair Cliff; Giulio Alessandri; Augusto Pessina; Daniele Spaziante; Marina Aralla
Journal:  Stem Cells Transl Med       Date:  2018-07-23       Impact factor: 6.940

Review 10.  Grapiprant: A snapshot of the current knowledge.

Authors:  Irene Sartini; Mario Giorgi
Journal:  J Vet Pharmacol Ther       Date:  2021-05-31       Impact factor: 1.786
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.